2016


To access this material please log in or register

Register Authorize
2016/№4

Expert Council report “Importance of using omega-3 polyunsaturated fatty acid ethyl ethers (ω-3 PUFA 90 %, g/g) after myocardial infarction with concomitant cardiac abnormalities”

Mareev V. Yu.
Federal State Budgetary Educational Institution of Higher Professional Education “M. V. Lomonosov Moscow State University”, Leninskie Gory 1, GSP-1, Moscow 119991

Keywords: omega-3 fatty acids, postinfarction cardiosclerosis, treatment

DOI: 10.18087 / rhj.2016.4.2260

  1. Burr ML. Reflections on the diet and reinfarction trial (DART). Eur Heart J. 2001;3 (Suppl D): D75–8.
  2. GISSI-Prevenzione Investigators. Dietary supplementation with n-3‑polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999 Aug 7;354 (9177):447–55.
  3. Poole CD, Halcox JP, Jenkins-Jones S, Carr ES, Schifflers MG, Ray KK, Currie CJ. Omega-3 fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retro­spective, matched-cohort study. Clin Ther. 2013 Jan;35 (1):40–51.
  4. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R et al. Effect on n-3 polyunsaturated fatty acids in patients with chro­nic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4;372 (9645):1223–30.
  5. Ghio S, Sceli L, Latini R, Masson S, Eleuteri E, Palvarini M et al. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail. 2010 Dec;12 (12):1345–53.
  6. Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ et al. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA. 2012 Nov 21;308 (19):2001–11.
  7. Chan DC, Watts GF, Mori TA, Barrett PH, Beilin LJ, Redgrave TG. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. Eur J Clin Invest. 2002 Jun;32 (6):429–36.
  8. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011 Jun 23;364 (25):2439–50.
  9. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyo­pathy. J Am Coll Cardiol. 2011 Feb 15;57 (7):870–9.
  10. Heydari B, Abbasi SA, Shah R, Abdullah S, Feng J, Harris W et al. Effect of purified omega-3 fatty acids on reducing left ventricular remodeling after acute myocardial infarction (OMEGA-REMODEL study): a double-blind randomized clinical trial. J Cardiovasc Magn Reson. 2015 Dec;17 (Suppl 1):07.
  11. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al. 2013 ACCF / AHA guideline for the management of heart failure a report of the American College of Cardiology Foundation / American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128 (16):e240–327.
  12. Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P., Authors/Task Force Members and Document Reviewers (2016), 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. doi:10.1002/ejhf.592.
  13. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П., Коротеев А. В., Мареев Ю. В., Овчинников А. Г. и др. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Журнал Сердечная Недостаточность. 2013;14 (7):379–472 [Mareev V. Yu., Ageev F. T., Arutyunov G. P., Koroteev A. V., Mareev Yu. V., Ovchinnikov A. G. i dr. Naczio­nal`ny`e rekomendaczii OSSN, RKO i RNMOT po diagnostike i lecheniyu XSN (chetverty`j peresmotr). Zhurnal Serdechnaya Nedostatochnost`. 2013;14 (7):379–472].
  14. Шляхто Е. В., Арутюнов Г. П., Беленков Ю. Н. Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти. Архивъ внутренней медицины. 2013;4:5–15 [Shlyaxto E. V., Arutyunov G. P., Belenkov Yu. N. Naczio­nal`ny`e rekomendaczii po opredeleniyu riska i profilaktike vnezapnoj serdechnoj smerti. Arxiv`` vnutrennej medicziny`. 2013;4:5–15].
  15. Инструкция по медицинскому применению препарата Омакор [Instrukcziya po mediczinskomu primeneniyu preparata Omakor].
  16. Аронов Д. М., Арабидзе Г. Г., Ахмеджанов Н. М., Балахонов Т. В., Бойцов С. А., Бубнова М. Г. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. V пересмотр. – М., 2012. – 50с. Атеросклероз. 2012;8 (2):61–94 [Aronov D. M., Arabidze G. G., Axmedzhanov N. M., Balaxonov T. V., Bojczov S. A., Bubnova M. G. i dr. Diagnostika i korrekcziya narushenij lipidnogo obmena s czel`yu profilaktiki i lecheniya ateroskleroza. Rossijskie rekomendaczii. V pere­smotr. – M., 2012. – 50s. Ateroskleroz. 2012;8 (2):61–94].
Mareev V. Yu. Expert Council report “Importance of using omega-3 polyunsaturated fatty acid ethyl ethers (ω-3 PUFA 90 %, g/g) after myocardial infarction with concomitant cardiac abnormalities”. Russian Heart Journal. 2016;15 (4):301–304

To access this material please log in or register

Register Authorize
Ru En